Pandox AB Class B

As of June 30, 2026, Pandox AB Class B carries a market capitalization of 3.05B, placing it among publicly traded companies globally. Its enterprise value stands at 7.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Pandox AB Class B's next confirmed earnings release is scheduled for February 4, 2027.

As of June 30, 2026, Pandox AB Class B has 194.60M shares outstanding.

As of June 30, 2026, Pandox AB Class B trades at a trailing price-to-earnings ratio of 10.37. The price-to-sales ratio is 4.30, and the price-to-book ratio stands at 0.97.

As of June 30, 2026, Pandox AB Class B trades at an EV/EBITDA multiple of 14.27 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 11.07 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.09 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 7.85B versus a market cap of 3.05B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Pandox AB Class B maintains a current ratio of 0.80, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 156.83, indicating elevated leverage, while an interest coverage ratio of 2.87 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Pandox AB Class B posted a return on equity (ROE) of 9.75, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 5.58 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.36, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 6.12, useful for judging operating efficiency across full business cycles. The company generates approximately 466,049.07 in revenue per employee across its workforce of 1,520.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 459.57 indicates how many times Pandox AB Class B sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Pandox AB Class B recorded 84.14M in income tax expense. That works out to an effective tax rate of 22.14, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 380.09M, leaving 293.87M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Pandox AB Class B's stock has declined approximately 11.74% over the past 52 weeks. The 50-day moving average sits at 14.70, while the 200-day moving average is 16.25.

Over the twelve months ended June 30, 2026, Pandox AB Class B generated 708.63M in revenue and converted that into 293.87M in net income, yielding earnings per share of 1.52. EBITDA reached 549.73M, while operating income came in at 397.51M.

As of June 30, 2026, Pandox AB Class B holds 147.79M in cash and equivalents against 4.93B in total debt, resulting in a net debt position of 4.45B. Total book value stands at 3.13B, with working capital of -414.94M providing operational flexibility.

Pandox AB Class B produced 372.51M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.37B in capital expenditures, free cash flow totaled -998.25M - equivalent to -5.13 per share.

Over the twelve months ended June 30, 2026, Pandox AB Class B posted a gross margin of 59.01, reflecting its pricing power and cost economics. The operating margin of 56.10 and net profit margin of 41.47 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Pandox AB Class B paid dividends of 0.79 per share. The dividend payout ratio of 51.61 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -32.76: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -24.76, meaning Pandox AB Class B raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Pandox AB Class B has an Altman Z-Score of 0.68, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.